Sonnet BioTherapeutics (SONN) Profit Margin (2010 - 2024)
Sonnet BioTherapeutics (SONN) profit margin from Jun 30, 2010 to Dec 31, 2024. The current Sonnet BioTherapeutics (SONN) profit margin is -316.00%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Sonnet BioTherapeutics (SONN)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -1601.00% | -95.70% |
| 2024 | -37200.00% | +196.34% |
| 2023 | -12553.33% | +47.84% |
| 2022 | -8491.43% | +63.17% |
| 2021 | -5204.17% | +8746.79% |
| 2019 | -58.83% | +163.90% |
| 2018 | -22.29% | +36.01% |
| 2017 | -16.39% | -24.73% |
| 2016 | -21.77% | -36.60% |
| 2015 | -34.34% | +60.12% |
| 2014 | -21.45% | -66.04% |
| 2013 | -63.15% | +36.46% |
| 2012 | -46.28% | -40.96% |
| 2011 | -78.38% | N/A |
| 2011 | -78.38% | -89.14% |
| 2010 | -721.43% | N/A |
| 2010 | -721.43% | N/A |
Comparison Sonnet BioTherapeutics (SONN) profit margin with competitors
Sonnet BioTherapeutics (SONN) profit margin is -316.00%.